Clinical Trial Update: Linezolid Instead of Ethambutol in Treatment of Drug-susceptible Tuberculosis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluates using Linezolid instead of Ethambutol for drug-susceptible pulmonary tuberculosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Tuberculosis

Drugs mentioned

• Ethambutol (ethambutol)
• Linezolid (Linezolid)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Pulmonary Tuberculosis Without Resistance to Rifampicin | Phase 2 | Status: UNKNOWN